Health-Related Quality of Life and Other Patient-Reported Outcomes in the European Centralized Drug Regulatory Process: A Review of Guidance Documents and Performed Authorizations of Medicinal Products 1995 to 2003-Reference-Cited by-同舟云学术

Health-Related Quality of Life and Other Patient-Reported Outcomes in the European Centralized Drug Regulatory Process: A Review of Guidance Documents and Performed Authorizations of Medicinal Products 1995 to 2003

Published:2005-09 Issue:5 Volume:8 Page:534-548
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Szende Ágota,Leidy Nancy K.,Revicki Dennis

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference44 articles.

1. New legislation update viewpoints of regulators and industry;5th European Regulatory and Scientific Conference;Drug Inf J,2002

2. The significance of quality of life in health care;Kaplan;Qual Life Res,2003

3. Measuring treatment impact. a review of patient-reported outcomes and other efficacy endpoints in approved product labels;Willke;Control Clin Trials,2004

5. Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001;Acquadro;Value Health,2003

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Oxygen–Ozone Adjunct Medical Treatment According to the Protocols from the Italian Scientific Society of Oxygen–Ozone Therapy: How Ozone Applications in the Blood Can Influence Clinical Therapy Success via the Modulation of Cell Biology and Immunity;Biology;2023-12-11

2. Inclusion of patient-reported outcome instruments in US FDA medical device marketing authorizations;Journal of Patient-Reported Outcomes;2022-04-20

3. Determinants of health-related quality of life decline in interstitial lung disease;Health and Quality of Life Outcomes;2020-10-08

4. How to Include Patient-Reported Outcome Measures in Clinical Trials;Current Osteoporosis Reports;2020-08-05

5. Cancer drugs for solid tumors approved by the EMA since 2014: an overview of pivotal clinical trials;European Journal of Clinical Pharmacology;2020-03-03